New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release

Viral Vector
Manufacturing

We develop and manufacture viral vectors that meet clinical and commercial demands for gene therapy products
Milan lab
Mammalian          Microbial        pDNA        Viral Vector        Cell Therapy        mRNA

CDMO Viral Vector Services

With our full-service viral vector offering, we can develop, manufacture, and optimize lenti (LVV), retro (RVV), and adeno-associated (AAV) viral vectors. 

Extensive Experience Through Commercial

Benefiting from over 30 years of industry-leading expertise and four commercially approved products, AGC Biologics is at the forefront of viral vector clinical and commercial manufacturing capabilities with substantial GMP capacity, approved by regulatory authorities.

AGC_Milano_015-1

Fast & Scalable Vector Production

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes. cGMP viral vector manufacturing for suspension-based processes provide up to 2,000 L. We also utilize iCELLis 500 bioreactor technology for adherent processes up to 200 L.

AGC_Milano_025-1

Full Lifecycle Development Systems

Our quality systems, manufacturing scales, and regulatory expertise allow us to meet both clinical and commercial viral vector demands. Moreover, our scale-down capabilities provide flexible and cost-effective solutions for process development and pre-clinical studies.

_MG_7894

Viral Vector Manufacturing Track Record

0

Years of experience

0

Commercial viral vector products

+0

Manufactured viral vector GMP batches

End-to-End Viral Vector Services

AGC Biologics scientists have three decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. Our scale-down capabilities provide flexible and cost-effective solutions for process development and pre-clinical studies.

Our quality systems, manufacturing scales, and regulatory expertise allow us to meet both clinical and commercial viral vector demands. 

Got a project? Let's talk.
AGC_laboratory_015

Our vector platforms that cut your timeline in half

End-to-end viral vector offerings give developers plug-and-play templates for the entire development and manufacturing process

Bravo logo 500px

Our templated adeno-associated viral vector platform.

Learn more
Pronto logo 500px

Our templated lentiviral vector platform.

Learn more

Listen to Expert Interviews from Teams at Our Cell & Gene Center of Excellence in Milan and Longmont

Click and drag video thumbnails to see more content.

Viral Vector Development from Clinical to Commercial

DSC_4498-1-1

Adhesion and Suspension

Small, medium, and large-scale equipment for both adherent and suspension processes.

_MG_7717-1

Plug-and-Play Platform

Plug-and-play platform for large-scale AAV and LVV manufacturing that can be adapted to virtually any program.

large-scale-aav-manufacturing-download-graphic1

Optimizing Large-Scale AAV Manufacturing

Learn about independent, innovative processes for producing high-quality, high-productivity AAVs.

Download

Like a Tailored Suit download graphic2

A Tailored Approach to Viral Vector Production 

A custom platform offers scalable, off-the-shelf manufacturing to accelerate your timeline to GMP and save costs. 

Download

Locations Offering Viral Vector Services


Interested in learning more?

Contact our team